Skip to main content
. 2023 Jun 18;13(4):157–168. doi: 10.5500/wjt.v13.i4.157

Table 3.

Infectious and non-infectious complications among the two groups, n (%)


Total, 105
Non-transfusion, 51 (48.6%)
Transfusion, 54 (51.4%)
P value
No. of infections 0 (0-1) 1 (0-1) 0 (0-1.25) 0.554
Types of infections
none 55 (52.4) 25 (49) 30 (55.6) 0.745
UTI 30 (28.6) 14 (27.5) 16 (29.6) 0.832
Pnemonia 1 (1) 1 (2) 0 (0) 0.486
TB 1 (1) 0 (0) 1 (1.9) 1
BK 7 (6.7) 5 (9.8) 2 (3.7) 0.261
Bactremia 4 (3.8) 1 (2) 3 (5.6) 0.618
Epidediymo-orchitis 2 (1.9) 1 (2) 1 (1.9) 1
Gastroenteritis 2 (1.9) 2 (3.9) 0 (0) 0.234
Herpes zoster 1 (1) 0 (0) 1 (1.9) 1
Infected AVF 1 (1) 1 (2) 0 (0) 0.486
Perianal abcess 1 (1) 1 (2) 0 (0) 0.486
COVID-19 9 (8.6) 6 (11.8) 3 (5.6) 0.311
URTI 2 (1.9) 1 (2) 1 (1.9) 1
CMV 12 (11.4) 6 (11.8) 6 (11.1) 1
Urological complications
None 95 (90.5) 49 (96.1) 46 (85.2) 0.484
Allograft artery stenosis 1 (1) 0 (0) 1 (1.9)
Collection 3 (2.9) 1 (2) 2 (3.7)
Lymphocele 1 (1) 0 (0) 1 (1.9)
Obstrctive uropathy 1 (1) 0 (0) 1 (1.9)
Perinephric collection and ureteric stricture 2 (1.9) 0 (0) 2 (3.7)
Unrogenic bladder 1 (1) 0 (0) 1 (1.9)
Urinary leak 1 (1) 1 (2) 0 (0)
Urological complications
No 95 (90.5) 49 (96.1) 46 (85.2) 0.094
Yes 10 (9.5) 2 (3.9) 8 (14.8)
CNI withdrawal 1 (1) 0 (0) 1 (1.9) 1
Duration from Tx 3 d
MMF withdrawal 1 (1) 0 (0) 1 (1.9) 1
Duration from Tx 3 d
Steroids withdrawal 0 (0) 0 (0) 0 (0)

UTI: Urinary tract infection; TB: Tuberculosis; AVF: Arterio-venous fistula; COVID-19: Coronavirus disease 2019; URTI: Upper respiratory tract infection; CMV: Cytomegalovirus; CNI: Calcineurin inhibitor; MMF: Mycophenolate mofetil.